[ Deciphera Pharmaceuticals raises $52M in Series C ]

Deciphera Pharmaceuticals has raised $52 million in Series C funding.

Founded in 2003, Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies.

The proceeds will enable Deciphera to advance its pipeline of novel oncology products into later-stage clinical development.

Funding  Series C
Founded  2003
Country  USA
City  Waltham, Massachusetts
Founder / CEO  Michael D. Taylor
Deal Size  $52M
Investors  Deciphera Pharmaceuticals
 Sphera Global Healthcare Fund
 Redmile Group
 Viking Global Investors
Previous Investors  SV Health Investors
 New Leaf Venture Partners